Inventor
SHIMMA NOBUO
JP35 patents
⚠️ This page may combine multiple inventors who share the name “SHIMMA NOBUO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
10 patentsUS5472949ADec 5, 1995
N4 -(substituted-oxycarbonyl)-5'-deoxy-5-fluorocytidine compounds, compositions and methods of using same
HOFFMANN LA ROCHE129 citations93
US4801584AJan 31, 1989
Pyrido(3,2,1-IJ)-1,3,4 benzoxadiazine derivatives
HOFFMANN LA ROCHE31 citations89
US6211166B1Apr 3, 2001
5′-deoxy-cytidine derivative administration to treat solid tumors
HOFFMANN LA ROCHE11 citations72
US6114520ASep 5, 2000
5'-deoxy-cytidine derivatives
HOFFMANN LA ROCHE14 citations72
US5962686AOct 5, 1999
N-benzylazolium derivatives
HOFFMANN LA ROCHE6 citations70
US4864023ASep 5, 1989
Pyrido(3,2,1-IJ)-1,3,4-benzoxadiazine derivatives
HOFFMANN LA ROCHE12 citations70
US6005098ADec 21, 1999
5'deoxycytidine derivatives
HOFFMANN LA ROCHE4 citations61
US5900486AMay 4, 1999
N-benzylazolium derivatives
HOFFMANN LA ROCHE4 citations59
US5719291AFeb 17, 1998
Cyclohexane derivatives
HOFFMANN LA ROCHE4 citations59
US5449785ASep 12, 1995
Cyclohexane derivatives
HOFFMANN LA ROCHE0 citations48
BASILEA PHARMACEUTICA AG
7 patentsUS6812238B1Nov 2, 2004
N-substituted carbamoyloxyalkyl-azolium derivatives
BASILEA PHARMACEUTICA AG47 citations95
US7459561B2Dec 2, 2008
N-substituted carbamoyloxyalkyl-azolium derivatives
BASILEA PHARMACEUTICA AG3 citations61
US7189858B2Mar 13, 2007
N-phenyl substituted carbamoyloxyalkyl-azolium derivatives
BASILEA PHARMACEUTICA AG1 citations61
US7151182B2Dec 19, 2006
Intermediates for N-substituted carbamoyloxyalkyl-azolium derivatives
BASILEA PHARMACEUTICA AG3 citations61
US6319933B1Nov 20, 2001
Azole derivatives
BASILEA PHARMACEUTICA AG0 citations52
US6849709B2Feb 1, 2005
Aerothricin derivatives
BASILEA PHARMACEUTICA AG1 citations50
US6489440B1Dec 3, 2002
Cyclic compounds
BASILEA PHARMACEUTICA AG1 citations48
CHUGAI PHARMACEUTICAL CO LTD
6 patentsUS7745663B2Jun 29, 2010
5-Substituted-2-phenylamino benzamides as MEK inhibitors
CHUGAI PHARMACEUTICAL CO LTD14 citations81
US8022205B2Sep 20, 2011
Pyrimidine derivatives as PI3K inhibitor and use thereof
CHUGAI PHARMACEUTICAL CO LTD11 citations80
US7109195B2Sep 19, 2006
Hexacyclic compounds and their therapeutic use
CHUGAI PHARMACEUTICAL CO LTD6 citations72
US6825194B2Nov 30, 2004
Hexacyclic compounds
CHUGAI PHARMACEUTICAL CO LTD6 citations72
US8362236B2Jan 29, 2013
Macrocyclic compound
CHUGAI PHARMACEUTICAL CO LTD2 citations59
US8048897B2Nov 1, 2011
Cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
CHUGAI PHARMACEUTICAL CO LTD0 citations41
ROCHE PALO ALTO LLC
3 patentsUS7608601B2Oct 27, 2009
4′-Substituted nucleoside derivatives as inhibitors of HCV RNA replication
ROCHE PALO ALTO LLC53 citations96
US7915232B2Mar 29, 2011
4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication
ROCHE PALO ALTO LLC26 citations91
US8648054B2Feb 11, 2014
4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication
ROCHE PALO ALTO LLC0 citations51